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Abstract
Effectiveness of Pelvic Floor Exercises in Women with Urinary Incontinence
Purpose: Urinary incontinence is common in women; especially those who have had one
or more vaginal deliveries. The purpose of our case study was to measure the
effectiveness of pelvic floor exercises and biofeedback in women with urinary
incontinence (VI) in a rural midwest physical therapy clinic.
Methods: Patients participating in this study were referred to a physical therapy clinic by
their physician for a urinary incontinence program. During the initial evaluations,
baseline biofeedback readings were recorded and home exercise programs were given.
Patients were then seen for follow-ups at approximately two weeks, four weeks, and three
months thereafter. Final biofeedback testing and completion of the three inventories
were performed at the three-month follow up.
Results: Due to a small sample size, we chose to display our results on an individual case
basis. Case study 1 showed improvement subjectively, however, did not improve in
objective measures. Case studies 2 and 3 showed improvement both in subjective and
objective measures.
Discussion: Limitations of our study included a small sample size, rural community
environment, lack of normative data for biofeedback, and time constraints. All three
patients reported subjective improvement from the UI program, and the continuation of
this study will help to determine the significance of this physical therapy intervention.
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Chapter I
INTRODUCTION
Urinary incontinence (VI) affects 13 million Americans, 11 million of whom ·are
women.! People with urinary leakage wait an average of seven to nine years to seek help
because they are embarrassed or think it is a normal part of aging; while eighty percent of
cases can be cured or improved.! Women's health is a growing area of the physical
therapy practice, and physical therapy intervention is a conservative method for treating
urinary incontinence.
PROBLEM STATEMENT
Surgery is a solution to this problem; however, a more conservative approach
includes physical therapy. This approach, as an adjunct to surgery or on its own, can
provide positive results in a less invasive, more convenient manner.
PURPOSE
The purpose of our study was to evaluate the outcomes of the UI physical therapy
program at a rural, upper midwest physical therapy clinic. Based on past research
conducted about pelvic floor exercises in patients with pelvic floor weakness, it has been
shown to benefit patients with this condition. 2,3,4
SIGNIFICANCE OF STUDY
This outcome study measured the effectiveness of a current UI program utilized at
the rural midwest clinic, with the new addition of two quality of life questionnaires - the

Urinary Distress Inventory(UDI-6) and the Incontinence Impact Questionnaire (IIQ-7);
and the Sandvik Incontinence Severity Index (ISI). These tools are discussed in detail in
Chapter II. This study did not experiment with new exercises; instead, conservative
exercises that were already being utilized in the clinic were used for the interventions.
The patients experienced the same standard of care the clinic provides all of their patients
with UI. Our research study was designed to evaluate the outcomes of conservative
interventions for women with pelvic floor weakness and incontinence at this particular
physical therapy clinic.
RESEARCH QUESTION
What is the effectiveness of pelvic floor exercises using results from biofeedback
and scores from subjective outcome surveys measured pre- and post-physical therapy
intervention?
HYPOTHESES
Null Hypothesis: Pelvic floor exercises do not have a significant effect on pelvic
floor weakness and incontinence scores measured by the Urogenital Distress Inventory
(UDI-6), Incontinence Impact Questionnaire (IIQ-7), Sandvik's Incontinence Severity
Index, Urine Stream Interruption Test, and biofeedback.
Alternate Hypothesis: Pelvic floor exercises have a significant effect on pelvic
floor weakness and incontinence scores measured by the Urogenital Distress Inventory
(UDI-6), Incontinence Impact Questionnaire (IIQ-7), Sandvik's Incontinence Severity
Index, Urine Stream Interruption Test, and biofeedback.
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Chapter II
LITERATURE REVIEW
ANATOMY
The pelvic cavity is composed of an anteroinferior wall, two lateral walls, a
posterolateral wall, a roof, and a floor. The floor consists of the coccygeus and levator
ani muscles. The levator ani is one of the most important muscles of the pelvic floor,
consisting of three parts: 1) puborectalis, 2) pubococcygeus, and 3) iliococcygeus. 5
Urinary incontinence can be classified into four primary categories: 6,7

1. Stress incontinence (SUI) occurs when the support for the bladder or urethra is
weak or damaged, but the bladder itself is normal. With stress incontinence, there
is involuntary loss of urine with activities that increase intraabdominal pressure
such as coughing, sneezing, laughing, lifting, exercising, or any other type of
physical exertion that increases pressure within the abdomen.

2. Urge incontinence (UUI), also known as overactive bladder, is the involuntary
contraction of the detrusor muscle (smooth muscle of the bladder wall) with a
strong desire to void (urgency) and loss of urine as soon as the urge is felt. Urge
incontinence is often related to reduced bladder capacity or detrusor instability. It
is often idiopathic but can be caused by medications, alcohol, bladder tumor,
neurogenic bladder, or bladder outlet obstruction.
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3. Overflow incontinence is the constant leaking of urine from a bladder that is full
but unable to empty. The client with incontinence from overflow will often report
a feeling that the bladder does not empty completely with an urge to void
frequently, including at night.

4. Functional incontinence occurs in people who have normal urinary control, but
who have difficulty reaching a toilet in time because of mobility or access deficits.
In addition to the four categories named above, some people can present with
more than one type of incontinence - most often stress and urge incontinence
together - known as mixed incontinence.
Vaginal delivery is an important risk factor in the development of urinary
incontinence. During childbirth, the fetal head is supported by the pelvic floor while the
cervix is dilating to allow fetal delivery. The levator ani may become damaged due to
stretching or tearing during childbirth. Abnormalities in the levator ani muscle are
present on MRI after vaginal delivery.s As a result of continued muscle weakness, the
position of the bladder and urethra may be altered which can potentially lead to stress
urinary incontinence.
Women who have become pregnant are not the only population at risk for urinary
incontinence; other contributing factors include gender, age, obesity, smoking, chronic
constipation, and participating in high-impact sports, to name a few.
EXERCISES

Physical therapists commonly treat pelvic floor dysfunction with conservative
techniques including pelvic floor exercises (often referred to as Kegel exercises) and
biofeedback therapy. Kegel exercises include both tonic and phasic contractions of the
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levator ani muscles that draw the urethra, vagina, and rectum toward the pubic bone. 9
Physical therapy intervention also includes oblique abdominal strengthening. Research
documents that conservative management is effective in treating many conditions
associated with pelvic floor dysfunction. 10 Pelvic floor exercises help to strengthen the
muscles that control the flow of urine and thus reduce the symptoms associated with
urinary incontinence. Practice of pelvic muscle exercise by primiparas results in fewer
urinary incontinence symptoms during late pregnancy and postpartum. II
Borello-France et al 12 concluded that exercise positions do not impact the
outcome in regard to bladder diary, pad tests, urodynamic tests, IrQ, and pelvic floor
muscle strength. They compared exercises done in supine only versus those done in both
supine and upright positions (anti-gravity). This is contradictory to previous ideas that
exercises performed in gravity-eliminated positions (supine) are less effective than those
performed against gravity.
BIOFEEDBACK
Biofeedback is a tool commonly employed by physical therapists with regard to a
variety of conditions. In the case of pelvic floor dysfunction, biofeedback is used as an
educational tool in order to teach patients to properly contract the muscles of the pelvic
floor. Patients may choose from internal or external electrode placement, although the
internal method is preferred as long as no contraindications exist. For external electrode
placement, the therapist places the electrodes in a ten o'clock and four o'clock positions
with reference to the anus. For internal placement, patients are instructed to insert it as
they would a tampon, with the sensor tab facing upward. After application of the
electrodes, patients are instructed to contract the pelvic floor muscles. As they are
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contracting, muscle activity is simultaneously recorded in a computer software program
and displayed upon a computer screen to allow the patient to see a visual representation
of the muscle contraction. This, in theory, teaches the patient how to correctly perform
pelvic muscle contractions without substitution from other muscle groups.
The biofeedback unit utilized at the clinic involved in this study is the Pathway
MR-20. There is no normative data in available literature. However, the physical
therapist involved in this study has found through her clinical practice a trend of resting
tone of the pelvic floor musculature to be less than 3 m V when the patient is supine and
less than 5 m V when the patient is sitting.
Capelini et al 13 conducted a study to evaluate the benefits of pelvic floor
strengthening exercises associated with biofeedback for the treatment of stress urinary
incontinence. The results concluded that treatment of incontinence with pelvic floor
exercises using biofeedback caused significant changes in the parameters analyzed, with
maintenance of good results three months after treatment. In addition, Glazer and Laine l4
critically reviewed 28 prospective, randomized studies with regard to pelvic floor muscle
biofeedback in the treatment of urinary incontinence. The overall mean treatment
improvement was 72.61 %. In 21 of 35 paired comparisons, biofeedback demonstrated
superior symptomatic outcomes versus control or alternate treatment groups.
QUALITY OF LIFE QUESTIONNAIRES: UDI-6 AND IIQ-7.
The Urinary Distress Inventory (UDI) and the Incontinence Impact Questionnaire
(IIQ) are quality of life questionnaires that pertain to urinary incontinence. When used
together, the UDI and the IIQ determine the effect that urinary incontinence has on
women's lives more clearly than generic health-related quality of life scales. IS The IIQ is
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a "life-impact assessment instrument specific to urinary incontinence" 16, pg.l32 and the
DDI is "specific to symptoms associated with lower urinary tract dysfunction and genital
prolapse.,,16,pg.132 For our study, the UDI-6 and the IIQ-7 were used, as they are quicker
to administer and have been found to be valid in comparison to their longer counterparts
(.93 and .97, respectively). 16 Both instruments are validated and useful in determining
the efficacy of treatment ofUI and are recommended by the Second International
Consultation on Incontinence l7 (see Appendix C).
SANDVIK INCONTINENCE SEVERITY INDEX (lSI)
The Sandvik lSI consists of two questions that establish the frequency and amount
of urine lost in women with UI. The frequency of urine lost is determined by the patient
as less than once a month, a few times a month, a few times a week, or every day and/or
night. The amount of urine lost is rated as drops or more. UI is then categorized as
slight, moderate, or severe by m~ltiplying the above scores (see Appendix C).
The lSI has been validated against p~d weighing tests in several studies. 18,19
Hanley et al 18 determined that the lSI is valid, reliable, and sensitive to measure urinary
incontinence in women, and therefore is recommended for routine use. The lSI has
received the highest recommendation from the 2 nd and 3rd International Consultations on.
Incontinence. 19
Murphy et afo concluded the Sandvik Incontinence Severity Index (lSI) is highly
correlated to the IIQ-7 and the UDI-6 in regard to post-treatment scores and percent
change from pre- to post-treatment. However, the pre-treatment IIQ-7 and UDI-6 scores
were not correlated to lSI scores.
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URINE STREAM INTERRUPTION TEST (UST)
The Urine Stream Interruption Test (UST), also referred by the primary physical
therapist as the Functional Faucet Test, is used to determine the pelvic floor strength of
women with stress urinary incontinence or to determine the effectiveness of a pelvic floor
strengthening program. The goal of the UST is to stop the flow of urine mid-stream. The
following were used as criteria for scoring: O=no deflection or change in stream;
1=slight deflection; 2= able to slow urine stream; and 3= able to completely stop the

flow. Based on theory, women suffering from SUI should not be able to stop the flow of
urine secondary to weak pelvic floor muscles.
The UST was examined by Sartore et al 21 and was determined to be an effective
outcome measure of women who have undergone treatment after a vaginal delivery.
Other benefits include its low cost, non-invasive nature, and ability to provide objective
information about pelvic floor muscles. However, other studies have not shown such
positive results. Onyeka et af2 concluded that the UST is a poor determinant of pelvic
floor muscle function because 87% of the women in the study with SUI were able to
perform the UST. They concluded it is not reliable to determine the success of treatment.
Urinary Incontinence is a common problem in many women. Based on current
literature, physical therapy intervention is a positive and reliable treatment for women
with urinary incontinence. The purpose of our study was to evaluate the outcomes of the
UI physical therapy program at a rural, upper midwest physical therapy clinic.
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Chapter III
METHODOLOGY
PARTICIPANTS
The patients that participated in this study included women who were referred to
an upper midwest physical therapy clinic by their physician for a urinary incontinence
program. Prior to beginning the program, all patients were given an explanation of the
study and signed consent forms (see Appendix B).
Eligibility for this study included women over the age of 18 with pelvic floor
weakness, stress UI, mixed UI (stress and urge), and uterine prolapse. Exclusion criteria
. were: males; women with post-surgical correction for urinary incontinence; state or local
prisoners; and women with cognitive disabilities. This study was approved by the
Institutional Review Board at the clinic facility and at the University of North Dakota
(see Appendix A).
Demographics included in this study represented three women who had
completed the program prior to this publication. Unfortunately, due to time constraints,
the researchers were only allowed a short period oftime to collect data on patients.
However, this particular study is long-term and is currently ongoing to more accurately
determine the outcomes of the pelvic floor program.
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Table 1. Demographics

3

Total number of participants

40-57

Age range

50

Average age

3wks-3yrs

Length of symptoms range
Average number of childbirths

3

Mixed UI

3

Uterine prolapse

2

INSTRUMENTATION
Biofeedback was performed at the clinic using their personal instrumentation.
Upon the patients' first appointments, they were instructed to complete two quality of life
questionnaires and a severity index - the Short Form of the Incontinence Impact
Questionnaire (IIQ-7), the short form of the Urogenital Distress Inventory (UDI-6), and
the Sandvik's Incontinence Severity Index (lSI). The lSI is scored by multiplying the
women's self-reported frequency ofUI by the self-reported amount of urine leakage, and
the women's self-perceived UI severity. The short form of the Urogenital Distress
Inventory (UDI-6) is divided into 5 subscales: discomfort/pain; urinary incontinence;
overactive bladder; genital prolapse; and obstructive micturition (see Appendix C). The
IIQ and the UDI-6 were both recommended by the Second International Consultation on
Incontinence and found to be valid. 17
Biofeedback was performed at the initial examinations and again at approximately
a three-month follow-up appointment. The desired resting tone biofeedback readings
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measured in microvolts in the pelvic floor and gluteal musculature is less than 3 mV in
supine or less than 5 mV in sitting. The patients chose to use external or internal
biofeedback electrodes, depending on their preference and/or any existing
contraindications. Biofeedback has been found to be reliable and of clinical use in
outcome analyses of interventions for urogenital symptoms in women.
However, overall studies show that reliability and validity can be controversial for
biofeedback. The physical therapist in our study treated all three patients, ensuring
reliability through biofeedback and external electrode placement. If the patient chose to
have internal electrode placement, it was inserted by the patient privately. The clinician
assured correct electrode placement on the patient prior to biofeedback readings.
PROCEDURE
All patient interventions were based on the clinic's current standard of care. The
patients received a letter and brochure from the clinic regarding the details of the urinary
incontinence program. This was done to increase the patients' awareness of the program
and to assure they did not have any questions prior to the examination and intervention.
All of the questionnaires, including the IIQ-7, UDI-6, and the Sandvik Severity Index
were given at the time of each patient's first appointment (see Appendix C). These
outcome tools were used along with subjective and objective data to collect pre-physical
therapy intervention data on the patients. These data included a general medical history,
brief obstetrical history (past pregnancies, miscarriages, vaginal deliveries, etc.), brief
urogynecologic history (prior urinary tract infections and incontinence issues), prior
surgical history, Functional Faucet Test estimate, and biofeedback testing of the pelvic
floor (see Appendix E).
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Prior to biofeedback testing, all patients were educated in the function of the
pelvic floor and received a brief overview of the anatomy through a pictorial diagram
(see appendix D). Standard positioning was utilized for all patients in the gravityeliminated position (supine). Handouts were given to the patient to imagine the pelvic
floor as a hammock for the bladder. The patient was instructed to maintain relaxed
breathing and to avoid talking or lower extremity movement during testing. Specifics in
regard to ratio of work/rest and positioning were individualized based on the Functional
Faucet Test score or whether a prolapse was noted per the physician. Contraindications
for biofeedback use with an internal electromyographic (EMG) sensor were read to the
patient. If no contraindications were noted, the patient privately inserted the sensor.
External electrodes were considered if the patient was not comfortable using the internal
electrodes or if internal electrodes were contraindicated. Placements of the external
electrodes were at a ten o'clock and four o'clock position with reference to the anus. For
internal electrode placement, patients were instructed to insert it as they would a tampon,
with the sensor tab facing upward. Two channels were used during the biofeedback
testing - channel A (pelvic floor) and channel B (right lateral gluteal region).
Throughout the biofeedback testing, patients were educated on the proper firing of the
pelvic floor muscles, both isolated phasic and tonic contractions (type one and two fibers),
without gluteal substitution. This testing was used for EMG baseline strength, for
increasing the patient's sensory input for accuracy in performing kegel contractions, and
for providing patient education for increased)awareness of the pelvic floor.
After biofeedback testing, all three patients received their initial written and
illustrative exercise program handout and proper demonstration of exercises (see
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Appendix D). A walking program was also advised with emphasis on the patient
performing transversus abdominus stabilization during ambulation. Patients were asked
to fill out a walking log, with the goal ofa minimum of three times per week for thirty
minutes (see Appendix D). Patients with urge UI were educated in their pathology
including: urge urinary suppression techniques; use of a bladder diary; education on
normal bladder habits; and avoidance of bladder irritants (see Appendix D).
After the initial session, the patients were seen at approximately two weeks, four
weeks, and three months thereafter. Final biofeedback testing and completion of the
three inventories were performed at the three-month follow up.
DATA COLLECTION
Outcome data was collected via chart review by the student researchers and
faculty advisor on-site at the physical therapy clinic. A form was developed to quickly
and easily gather the data from each patient's initial and final examination physical
therapy notes (see Appendix E).
DATA ANALYSIS
Simple descriptive statistics were used to analyze data for this study.
Comparisons were made between scores from the initial and final testing results.
REPORTING OF RESULTS
Upon completion of this study, a summary of results were given to the University
of North Dakota Department of Physical Therapy, the Harley E. French Library of Health
Sciences, and to all of the researchers involved in the study. This study was completed as
partial fulfillment of requirements for the University of North Dakota School of Medicine
and Health Sciences Physical Therapy Program.
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Chapter IV
RESVLTS
The following results are displayed as an outcome study based on chart reviews of
three separate patients. The results were not compared between patients, but were based
on each patient's baseline to final biofeedback results, Sandvik Severity Scale, VDI-6,
IIQ-7, and subjective reports of improvement.
CASE STVDY 1
The patient in case one was a 53 year-old female who was post-menopausal and
presented with symptoms of mixed urinary incontinence, stress VI being the primary
complaint and urge VI being the secondary complaint. Symptoms for this patient were
brought on with coughing, sneezing, laughing, lifting, and exercise. Frequency of
urination was seven times per day or greater. The onset of symptoms began about 1.5
years prior to her initial examination. The patient's general medical history was
unremarkable, but obstetrical/urogynecological history revealed that she was a multipara
who vaginally delivered two children, the largest weighing six pounds and one ounce.
Neither delivery required an episiotomy or the use of forceps. Medications/supplements
for this patient included occasional aspirin as needed, multivitamins, and additional
vitamin E. She was a non-smoker who consumed caffeine (one cup of coffee per day) on
a regular basis and alcohol on occasion. She also took in approximately 72 ounces of
non-caffeinated fluid daily. Prior to the onset of her urinary incontinence, the patient was
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participating in aerobic exercise four to seven times per week and also walking five miles
two to three times per week. After the onset of urinary incontinence, her frequency of
activity declined to zero to three times per week.
EXAMINATION AND INTERVENTION

Initial and final examination results are reported in Table 2. The patient was
given standard protocol exercises as described in the methods section.
FINAL EXAMINATION

The patient reported feeling 50% better at this time, although the urge UI was still
present. At final examination, the patient was walking one time per week for three and a
half miles. She was also attempting aerobics two times per week and noted no UI during
exercise. However, she planned her fluid intake around these activities. Biofeedback
changes from initial to final showed that while her pelvic floor muscle contractions were
slightly weaker, she was using less gluteal substitution. Her UDI-6 score did not change
during the three months, but her IIQ-7 decreased from 28.57 to 19.05.
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Table 2. Initial and Follow-up Data for Case Study 1
Initial

Final

Height (inches)

60

60

Weight (pounds)

110

112.S

Body Mass Index

21.S

22

UST Score

2-

2+

lSI Score

8

8

UDI-6

SOl100

IIQ-7

28.571100

19.0S/100

Not available

Not available

Voiding at night

SOl100

Biofeedback electrode placement

Internal

Internal

Biofeedback: Pelvic Floor (Resting Tone)

4.SmV

S.OlmV

Biofeedback: Pelvic Floor (Phasic)

13;4mV

11.4mV

Biofeedback: Pelvic Floor (Tonic)

13.lmV

11.4mV

Biofeedback: Gluteals (Resting Tone)

1.04mV

unknown

Biofeedback: Gluteals (Phasic)

2.33mV

.70mV

Biofeedback: Gluteals (Tonic)

3.70mV

.74mV

Tonic Holding Ability

Not available

Not available

Work-Rest (Phasic)

3.25mV

1.49mV

Work-Rest (Tonic)

6.95mV

4.l2mV
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CASE STUDY 2
The patient in case two was a female of 57 years who was post-menopausal and
presented with symptoms of mixed urinary incontinence, stress UI being the primary
complaint and urge UI being the secondary complaint. Symptoms of stress UI began
gradually over the past two years prior to the initial examination. Urgency was brought
on approximately four weeks preceding the examination. General medical history for
this patient revealed that she had undergone three breast biopsies, none of which were
recent. She also related sacroiliac/low back pain. With regard to
obstetrical/urogynecological history, she reported occasional dyspareunia (painful
intercourse) and had a mild uterine prolapse. She was a mUltipara who gave birth four
times to five children (one set of twins). She underwent a cesarean section for the twin
birth. There were a total of two episiotomies and two forceps deliveries throughout all
four births. The largest child weighed in at 9 pounds and 12 ounces. Her medications
included Lexapro, Lipitor, Lorazepam, and Imipramine. She was a non-smoker who
regularly consumed fluids that are known irritants to the bladder such as pop and green
tea, in addition to occasional alcohol. Non-caffeinated fluid intake was approximated at
20 ounces per day. Activity level prior to symptoms ofUI consisted of a walking
program. At the time of the initial examination, the patient was participating in a
Curves® program three times per week with low impact activities in addition to walking

four to five times per week for one to two miles each session.
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EXAMINATION AND INTERVENTION

Initial and final examination results are reported in Table 3. The patient was
given standard protocol exercises as described in the methods section.
FINAL EXAMINATION

The patient reported feeling 60% better at this time, with absence of SUI.
She participated in exercise five times per week for 45 minutes and a home exercise
program was completed daily. Biofeedback changes from initial to final showed that her
pelvic floor muscle contractions increased along with her gluteal substitution. Both her
UDI-6 and IIQ-7 decreased over the three-month period going from 44.44 to 16.67, and
14.29 to 0, respectively.
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Table 3. Initial and Follow-up Data for Case Study 2
Initial

Final

Height (inches)

64.5

64.5

Weight (pounds)

165

163

Body Mass Index

27.9

27.5

UST Score ·

3

Not Available

lSI Score

4

2

UDI-6

44.44/100

16.671100

IIQ-7

14.29/100

01100

Voiding at night

3 times

3 times

Biofeedback electrode placement

External

External

Biofeedback: Pelvic Floor (Resting Tone)

1.38mV

2.34mV

Biofeedback: Pelvic Floor (Phasic)

6.45mV

12.3mV

Biofeedback: Pelvic Floor (Tonic)

8.94mV

14.2mV

Biofeedback: Gluteals (Resting Tone)

.84mV

Not Available

Biofeedback: Gluteals (Phasic)

1.04mV

3.50mV

Biofeedback: Gluteals (Tonic)

1.44mV

2.65 mV

Tonic Holding Ability

5 seconds

Work-Rest (Phasic)

3.72mV

4.29mV

Work-Rest (Tonic)

6.86mV

11.0mV
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Not Available

CASE STUDY 3
The patient in case three was a female, aged 40, who had a diagnosis of mixed
urinary incontinence and uterine prolapse. Her primary complaint was urge UI, which
had been present for the past three years. She also had a secondary complaint of stress UI
with symptoms existent for three months preceding the initial evaluation. Frequency of
urination was approximately ten times per day, with two to three urinations at night.
General medical history revealed that this patient had undergone a laparoscopy and a
scoping of her right knee about two years prior to the examination. With regard to
obstetricallurogynecological history, she was diagnosed with pelvic inflammatory disease,
and also dyspareunia. This patient had eight pregnancies, three miscarriages, two
r

abortions and three completed full term births. The largest child weighed eight pounds
and ten ounces. One delivery required an episiotomy. She also reported a history of
abuse. She was a non-smoker who consumed up to four caffeinated beverages on a
regular basis and alcohol on occasion. Current exercise at the time included biking for 30
minutes every other day.
EXAMINATION AND INTERVENTION
Initial and final examination results are reported in Table 4. The patient was
given standard protocol exercises as described in the methods section.
FINAL EXAMINATION
The patient reported feeling 50% better at this time. She was walking one to two
miles, four times per week and her home exercise program was performed two to three
times a week. She also lost 13.5 pounds over the three-month period. Biofeedback
changes from initial to final show that her pelvic floor muscle contractions increased
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along with her gluteal substitution. Both her UDI-6 and IIQ-7 decreased over the threemonth period, changing from 50 to 44.44 and 28.57 to 9.52, respectively.
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Table 4. Initial and Follow-up Data for Case Study 3
Initial

Final

Height (inches)

64.25

64.25

Weight (pounds)

206

192.5

Body Mass Index

35.1

32.8

UST Score

2

2+-3

lSI Score

8

4

UDI-6

501100

44.44/100

IIQ-7

28.57/100

9.52/100

Voiding at night

2-3 times

1-2 times

Biofeedback electrode placement

Internal

Internal

Biofeedback: Pelvic Floor (Resting Tone)

1.79mV

1.95mV

Biofeedback: Pelvic Floor (Phasic)

13.6mV

15.9mV

Biofeedback: Pelvic Floor (Tonic)

19.0mV

23.4mV

Biofeedback: Gluteals (Resting Tone)

.31mV

unknown

Biofeedback: Gluteals (Phasic)

.39mV

.81mV

Biofeedback: Gluteals (Tonic)

.51mV

.93mV

Tonic Holding Ability

7 seconds

Work-Rest

15.5
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9 seconds
21.5

Chapter V
DISCUSSION/CONCLUSION
Patient one reported feeling 50% better at discharge. Her frequency of exercise
increased to walking one time per week and also performing aerobics two times per week,
without reports of urinary incontinence. Although biofeedback testing revealed that her
pelvic floor muscles were weaker than at the initial evaluation, she was able to decrease
substitution by the gluteal muscles. With regard to the IIQ-7, she did show improvement.
The second patient reported a 60% improvement at completion of the program,
with complete elimination of stress urinary incontinence. Her pelvic floor muscle
strength improved, but she also used more gluteal muscle substitution. The scores for the
UDI-6 and IIQ-7 both decreased, which was a positive effect.
The third and final patient also stated that she felt 50% better at discharge. She
increased her pelvic floor muscle strength, but she also increased the usage of her gluteals.

In addition, there were decreases in symptoms reported on both the UDI-6 and IIQ-7.
With respect to reporting changes in scores for these three patients, there was
some concern. The numbers that were assigned to each patient's score on the
questionnaires had no inherent mathematical relationship. In other words, they were
nothing more than a categorical label and had no arithmetic properties. Therefore, they
were not interpretable for our purposes. 23 We were able to report increases or decreases
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in performance, but we could not necessarily state the patients' levels of improvement
unless it was their own subjective reports.
These three case reports demonstrate the effects that pelvic floor exercises can
have on symptoms of urinary incontinence. Although there were not large changes with
regard to the results of biofeedback readings, all three patients had subjective reports of
feeling at least 50% better at discharge. A patient's perception of hislher own condition
can be as valuable, or even more valuable, than objective measurements. If a patient
shows significant changes in objective measures but does not necessarily "feel better,"
then the outcome of the treatment cannot truly be successful.
Several limitations were noted with this study, the first being a very small sample
SIze. Our intention was to design an outcome study to investigate the effectiveness of
pelvic floor exercises, but due to the limited number of participants, using a case study
format was the only plausible alternative.
Another drawback to our study was the lack of normative data for biofeedback
readings. The therapist that worked with the three patients has normative data that was
provided to her when the biofeedback system was purchased. She uses these numbers to
evaluate the effectiveness of her intervention program, but there are no normative
guidelines in scientific literature with respect to biofeedback that we are aware of.
Because of this, it is impossible to ascertain whether or not the results are significant.
The final limitation that we noted was the narrow time frame. New patients were
only eligible to participate between the months of June and August of2007. Information
was recorded at the initial examination and approximately three months later. Long-term
effects of the intervention program are unknown.
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There are several options for improving the design of a future study similar to this
one. Conducting the research in a more populated area would ensure a more optimal
number of participants. If the researcher would want to determine the significance of the
results, he/she would have to establish normative data with regard to biofeedback. Also,
long-term effectiveness could be verified by follow-up examinations at perhaps six
months or one year post-intervention.
Urinary incontinence is not a rare occurrence in women, especially in those who
have become pregnant. Fortunately, physical therapy intervention utilizing exercise
therapy can help improve symptoms in most of these cases, therefore eliminating the
need for surgical intervention for many patients. Although the symptoms of urinary
incontinence can often be decreased, many women do not seek help due to feelings of
embarrassment about their condition. In more recent years, though, the physical therapy
specialty field of women's health has continued to expand, resulting in more women
becoming aware of treatment options for many women's issues.
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Appendix A

Uiliversity of Nortll Dakota Human Subjects Review Form
All research witlLhurnan participants conducted by faculty, staff, and students associated with the University of
North Dakota, must.be reviewed and approved as prescribed by tbe University's policies and procedures goveming
the use of human subjects. It is tbe inte!)t of the University of North Dakota (UND), ·through the Institutional
Review Board (IRl3) and Research Development and Compliance (RD&C), to assist investigators engaged in
human subject research to conduct · their research along ethical guidelines reflecting. professional as well as
community standards. The University has an obligation to ensure that all research involving human subjects meets
regulations established by the United States Code of Federal Regulations (CFR). When completing the Human
Subjects Review Forn}, use the "IRl3 Checklist" for additional l,'1Iidance.
Please provide theinformation requested below:
PriliCipal
Investigators:

Cindy Flom-Meland
E-mail Address: cfmeland@medicine.nodakedu

Telephone: (701) 777-4130
Complete Mailing
Address:
.

Stop 9037

School/Colleg Uhiversity Of North Dakota School of
e:
Medicine and Health Sciences
Student Adviser (if
applicable):

Department: Department of Physical Therapy

Cindy Floin-Meland, PT, PhD, NCS

Telephone: (701) 777-4130

E-mail Address: cfmeland@medicine.nodalc.edu

Address or Box Stop 9037
#:
SchoollColleg University of North Dakota School of
e:
Medicine
and Health Sciences.
.

Department: Department of Physicaf Therapy

Projec{Title: Effectiveness of Pelvic Floor Exercises in Women with Urinary hlcontinence

Proposed Project Dates: Beginning
Date:

May 2007

Completion Date:

December 2009
(Including data analysis)

Funding agencies suppor~ng this
research:
.

Did the contrachvith the iunding entity go through UND Grants and Contracts Administration?
0 YES
or cg) NO
.
Attach a copy of the contact. Do not include the any budgetaryinfonnation. The IRE will not be able to review the
study without a copy of the contract with the funding agency.
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·1

'YES

Oor

~ 'NO

YES
~ or

0

Does any researcher associated with this project have a,n economic interest in the research, or
act as an offic:er or a director of any outside entity whose fmancia! interests would reasonably
appear to be affected by the research? If yes, submit.on a separate piece of paper an
additional explanation of the fmancialinterest. The Principal Investigator and any researcher
associated with this projcct should have a 'F inancial Interests Disclosure Document Oll file
with their department.

WiII research subjects be recruited at another organization (e.g., hospitals, schools, \'1\.1CA) ,or
NO will assistance with the data coliecticin be obtained from another organi7..ation?

If yes, list aJI
(!,rot-ihlt-;nnC'O

Letters from each organization must accompany this proposal. Each letter must illustrate that the organization
understands their involvement in that study, and agrees to participate in the study. Letters must include the name
and title of the individual signing the letter and should be printed on letterhead.
Does any cxternal site where thc research will be conducted have its ownIRB?

[gJ YES

If yes, does the external site plan to rely on UNO's IRE for approval oHhis study?

0

(If yes, cOlltact the UND IRE at 701 777-4279 for additional requirements)

0

NO

0 Nt A

YES ~ NO
,

0

NtA

If your project has been or will be submitted to other IREs, list thoseBoards berow, along with the status of each
proposal.

Date
submitted:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date

------------------------------

April
2007
..::..:..:..:....-- Status:
_ _ _ _ $tatus:

0
0

Approve
d
Approve

~Pending

o Pending

Type of Project: Check "Yes" or "No" for each of the follO\ving.

0

YES
or

D .NO

D

YES
or

0

YpS
or

0

YES
or

0
0

YES
or
'YES
or.

NO Dissertation/Thesis/Independent
YES or , ~ Study

New Project

o

~ NO

ContinuationlRenewal

~ YES or

~ .NO

Is this a Protocol Change for pJ'cviously approved project? If yes, submit a signcd copy of this
form with the changes bolded or highlighted.

o NO

Docs your project involve abstracting medical record infonllation? If yes, complete thc HJi>AA
Compliancc Application and submit itwith this form.

~ NO

Does your projcct include Genetic Research?

~ NO

Docs your projcct include Intemct Research?

0

NO

Student Researcli Project

Subject Classification:· This study will involve subjects who are in the following &llccial populations: Chcck aU
th<\tapply.

D

o
o
o

0

Children « 18 years)

o

PrisOliers

UND Studcnts
Pregnant WomenlFctuses

Persons with impaired ability to understand their involvement and/or consequences of participation in this
research
Other

----------------------------------------------------~R~e-v~is-e~d~1~O/~1~5/~O~G-' 2--
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Please use appropriate checklist when children, prisoners, pregnant women, or people who are unable to consent
will be involved .in the research.
This study will involve: Check all that apply.

D

Deception (Attach Waiver or Alteration of Infonned

D
D

Radiation

Consent Requirements)
New Drugs (lND) IND#

Attach Approval

D

Investigational Device Exemption (IDE) #
Approval

D

Non-approved Use ofDrug(s)

~

None of the above will be involved in this study

Attach

o
o
o
o
o

Stem Cells
Discarded Tissue
Fetal Tissue
Human Blood or Fluids
Other

1. Project Overview
The purpose ·o f our study is to measure the effectiveness of pelvic floor exercises and biofeedback on women with
Physical Therapy clinic. Based on past research
pelvic floor weakness and incontinence in a lural
conducted abourpelvic floor exercises in patients with pelvic floor weakness, it has been shown to benefit subjects
with this condition. We want to reinforce that the exercises being perfonned at
arc statistic!llly
beneficial for their patients. C.o nservative exercises are aiready being utilized in the clinic. This study docs not
·experimelit with new exercises. The patients will be experiencing the same standard of care that
provides all
of their patients with pelvic floor weakness and'prolapse.
.

II. Protocol Description
Please provide a succinct description of the procedures to be used by addressing the instructions under each of the
following· categorics.
•

.1. Subject Selection.
a) Women with pelvic floor weakness, StressUl, Mixed Ulinary Incontinence (Ul) (stress and urge) and prolapse,
by a physician. The period that subjects will berecluited
referred to .
is from May 2007 until December 20.09.
b) Subjects will be refem:d to
forPT by a Physician. Subject acceptance will be
detennined by the Physical Therapist's discretion (Women with pelvic floor weakness, Stress Ulinary Incontinence,
Mixed Urinary Incontinence (stress and urge) and prolapse). Participation in this study is voluntary for the patients.
c) Subjects excluded include: males, women post-surgical correction for UI, history ofpel\':ic cancer, severe
endometriosis, and usc oran intrauterine device.
d) About two hundred subjects will be recruited. The physical therapist we are working with states she acquircs
about one new patient with pel\':ic floor problems per week.
e) Power analysis was not completed.

2. Description of Methodology.
a) We devised an infonned consent foml through the University of North Dakota and also ·
(see attached).
b) The examination will be perfomled at ·
from UND will be collecting data at the
the University.

. by the Physical Therapist. Students
facility through chart review and running statistical tests at
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c) Cindy Flom-Meland, PT, PhD, NCS; Lisa Martin, MPT; Brittany Carter, SPT; Kayla Bucher, SPT; Rachel
Hanson, S;PT; Ashley Waller, SPT
d) All subjects referred for PT at the
for ur will receive a
general letter and brochure from the clil1lc regarding the program and the research study. Informed consent
and outcome queStionnaires (see attached) will be completed at the time of the subject's arrival on admit.
Physical therapy infcrvention will be carried out by Lisa Martin, MPT as per standard of care at the clinic.
Data collection via chart review "''ill be conducted by Cindy Flom-Meland, 1'1' ,md student research assistants
(listed in 'f below). Data collected from the chalts will consist of the three outcome questionnairesalld
cxamination information (please see data collection form) . Data will be collected upon admission and at
discharge from PT services (at approximately 3 months post initial visit).
e) Not applicable.
f)

Lisa Martin, .MPT, has been a physical therapist for 15 years. She has received advailced,tnlining in the area
of women's health specifically physical.therapy for urinary .incontinence. Cindy Flom~Meland has been a
physical therapist for 16 years and has been involved in research for the past 8 years. Kayla Bucher, Brittany
Carter, Rachel Hanson and Ashley Waller are all students of physical therapy and are participants in this
scholarly project in partial fulfillment towards their DPT.

g) There is no compensation for the subjects involved in this study.

Attachments Necessarv: Copies of all illstruments (such as surveylilltervielP questions; tlata collectiim forllls
completed by .mbjecLv, etc.) II/llst be attuched to tit is proposal.
3. Risk Identification.
a) This type of exercise is considered lowcrisk, however, v{ith any form of exercise; there can be some risk for
. inj ury. If injury shoUld occur, you and your third party payer will be responsible for all charges. There might
also be some mild discomfort regarding placement.of internal muscle activi.t y equipment if you choose to do
so. This discomfort should be minimized with use of visual aides and education of procedure.
b) Each subject will be given a code that will go on thc consent and all PT forms. 'This code will remain constant
throughout the study in order to assess efficacy oftreaunehrfrom evaluation to three months of therapy.
c) Ibere is no research that involves greater than minimal risk.
d) Does not apply.

4. Subject Protection.
a) Each subjcct will be given a description of tile procedure and its risks and benefits and be asked to sign a
consent form. The subjects will be assured that the procedures of the study arc the typical slandarcl.ofpractice
for their condition and that the researchers are measuring treatment effectiveness with use of the outcome
assessmenl,.
b) Each subject will be given a code that will go on the consent and all PT fOlms . Ibis code will remain constant
throughout the study in order to assess efficacy of treatment from evaluation to three months oftherapy.
c) The PTwill provide the subjects with a copy of the consent form at their initial examination,

d)
1) Research data will be stored in a locked file in a locked office for three years. The research dat~ will be
Revised lO/iSiOG
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kept separate fi·om the consent forms alldsubject personal data.
2) ·nlcprineipal investigators and collaborators will have access to the data. (Cindy Fiom-Meland, Lisa
Martin, Kayla Bucher, Brittany Carter, Rachel Hanson and Ashley Waller).
3) Three years after completion of the study data will be shredded.
4) Consent forms and personal data will be stored in a locked file in a locked office for three years. The
consent forms and subject personal data will be kept separate from the research data.
5) Three years after completion of the study consent fonns will be shredded.
e) Since this study is investigating typical physical therapy interventions any adverse reactions \Viii be handled
in a usual way. Adverse reactions to these procedures are rare, but in the event one does occur, the subject
will be referred back to see her physician. Thcre might also be some mild discomfort regarding plal'cment of
internal muscle activity equipment, if the subject choos(!s internal placement. TillS discomfort should be
minimized with the use of visual aides and education of pro cediIre.

f) This type of exercise is considered low"risk, however, with any form of exercises; there can be some risk of
injury. rf"injury should oecur"the subject and their third party payerwill be re~'Ponsible for?1l charges. As
stated above subject will be refelTed back to her physician ifthere are,any adverse re~ctions .

ill:

Bellefit.~ , of the Study
Conservative exercises are already being utilized in the clinic. Our research st\ldy is designed to evaluate how
effective the couservative treatment in women with pel vic floor weakness and incontinence. This study does 110t
expeliment with,new elCercises. The patients will be experiencing the same standard of care that
provides
all of their patients with pelvic floor weakness and prolapse.

IV. Consent Form
See attached
Necessary attacinnents;
~ Signed Student Consent to Release of Educational Record Form (students only);
~ 'h westigator Letter of Assurance of COinpliance;
~ Consent fom1, or Waiver or AiteI"'dtion ofInfonned Consent Requirements (FOIID IC 702-B)
~ Surveys, interview questionS, etc. (ifapplicable);

DPrinted web screens (if survey is over the futernet); and
D AdvertisementS.

ny signing below, you are verifying that the information provided'ill the Human Subjects RevieVl' Form and
attached
information' is accurate and that the project 'fI'ill be completed as indicated.

Signatures:

__~~F(mn_-~~~~=-___________4_-~~~-~a~-I____________
(plincipal rn~5tigator)

Date:

(Student Adviser)

Date:

Rcvis,ed lOi15iOG
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Th'"VESTIGATOR LETTER OF ASSURAJ.""l"CE OF COMPLL4NCE
VrTIll ALL APPLICABLE FEDERAL REGuLATIONS FOR THE
PROTECTION OF THE RIGHfS OF HUMAN SUBJECTS

agree that, in conducting research under the approval of the University of North Dakota Institutional Review Board, I
will fully comply and assunle responsibility for the enforcement of compliance with all applicable federal regulations
and University policies for the protection of the rights of human subjects engaged in research. Specific regulations
include the Federal Cornmon Rule for Protection ofthe Rights .bf Human Subjects 45 CFR 46. I will also assure
compliance to the ethical principles set forth in the National Commission for the Prbtectionof I-Iuman Subjects of
Biomedical and Behavioral Research document, The Belmont Report.

I understand the UiJiversity's policies conceming research involving human subjects and agree to the following:
1. Should I wish to make changes in .the approved protocol for this project, I will submit

them for revjew
PRIORtoinitiating the changes. (A proposal may be changed without prior IRB approval where necessary
to eliminate apparent immediate .hazards to the sUbje.cts or others.lfowever, the iRE must be notified in
writing within 72 hours of any change, and IRB review is required at the next regUlarly scheduled meeting of
the fuUIRB.)

2. If any problems invol ving human subjects occur, I will immediately notify the Chair of the IRB, or the.IRB
Coordinator.

3. I will cooperate with the UND IRB by submitting Research .Project Review and.ProgressReports in a timely
.manner.

I understand the failure to <:10 so mayresultin the suspension or termination of proposed research and p·ossiblc
reporting to federal agencies.

InvestiiatOfSlGature

.

Date
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HIPAA Compliance Application
Research Development and Compliance, University of North Dakota
1'0 Box 7134, Tv."dmiey Hall, Room 105, Grnn~ Fork~, North Dakota 58202
FW A-00000376/IRB-0000 I 040
Phone: (701) 777-42791 Fax: (701) 777-6708 http://www.und.nodakcduldeptlorpdlrcgucolfUll'1RB/index.html

PROJECT TITLE
Effectiveness of Pelvic Floor Exercises in Women with Urinary Incontinence
PRINCIPAL INVESTIGATOR
Flam-Meland, Cindy
Pleasc complete this form if you intend to use/disclose protected health information (PHI) in your
research. PHI is health infomlation transmitted or maintained in any form or medium that: identifies or could
be used to identifY an individual; is <-Teated or received by a healthcare provider, health plan, employer, or
healthcare clearinghouse; and relates to the past, present, or future physical or mental health or condition of an
individual; the provision of health care to an individual; or the past, present, or future payment-for the provision
of health care to an individual
An inycstigator may access PHI using one or more of the following methods, On less otherwise noted, you
should complete this entire form as applicable.
A. l'lease check the appropriate box(es) for your specific research.
I.

0

De;identified Information: De-identified Infonnation is health information that cannot be linked
to an indiviOual. Research which involves the use of "de-identificd" r>HI is. exempt from HIPAA
requirements. The HIPAA Privacy Rule regulations [45 CFR l64.514(b)] lists 18 specific
identifiers that must be removed from the health infonnation before the researcher obtains the
information for it to be considered not identifiable. The list includes: Name/initials; Street
address, city, county, precinct, zip code and equivalent geocodes; All elements of dates (except
year) directly related to an individ,mI. (date of birth, admission date, discharge date, date of
death); Elements of ciate, including year, for persons 90 or older; Telephone number; Fax
number; Electronic mail address; Social Security Numbcr; Medical re~oid numbers; Health plan
identification numbers; Account numbers Certificate/license numbers; Vehicle identifiers and
serial numbers, including license plate numbers; Device identifiers and serial numbers; Web
addresses CURLs); Internet IP addresses; Biometric identifiers, including finger and voice prints;
Full face photographic images and any comparable images; Any other unique identifYing
nwnber, characteristic or code.

If the research does 110t include access to any of the above identifiers, sign thc cettification at the
hottom of the page. The HIPAA privacy regulations do not apply and you are not required to
complete the rest of the application.
(Sign and Date this section only if the research involves De-Identified Information)
I certify the PHI received or reviewed by research personnel for the research referenced above
does lIot include any of the identifiers listed above.

Principal Investigator Signature

Date
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2.

0

Limited Data Set: A limited data sct is a subset of infonnation (PHI) that only contains the
following identifiers linked to the subject: city, state, zip code, or elements of date such as date
of birth, death or service. The other specific identifiers included in the list above may not be
included in the health infol1nation that is being received by the research team. The use of a
Limited Data Set requires a Data Use Agreement to be in place. The Data Use Agreement is a
legal contract between the covered entity and the recipient.
.

3. [gI Patient Authorization: A patient authorization is a document, signed by the subject that gives the
rese~cher pernlission to use/disclose PHI collected during the research study for defi.ned
purposes. An Authorization Fonn needs to be prepared in addition to the Infornled Consent
Document. The authorization infonnation may also be addressed in the consent fonn . Please
prepare the AuthOlization Fonn and submit it with your IRE application.
4.

0

Waiver/Alteration: A waiver/alteration is a request to forgo the authorization requirement based
on the fact that the use and/or disclosure of PHI involves minimal dsk to the subject's privacy
and the research cannot be practically done without this waiver/alteration and access to/usc of
PHI. Refer to Section H to see if you may qualify for a waiyer/alteration. Please designate if a
waiver is being sought for initial recruitment purposes or tor the entire research protocol.
Once a waiver of Authorization is granted, contact your source of PHI (i.e. Health Infonnation
Management) fo ensure that you follow the a<;counting procedures established as required by the
Plivacy Rule. Per the Pdvacy Rule, the covered entity must receive documentation of the
waiver/alteration before·PHI can be used or disclosed for the research.

The categories listed below are additional opportlmities alIo'wedundcr the HIPAA Privacy Rule to
view/record PHI without prior individual authorization.

B.

5,

0

Reviews PreparatOlY to Research: Preparatory work is when PHI is reviewed for the purpose of
designing a research study or identifying potential subjects. No infOlmation may be removed
from the records.

6.

0

Research on Decedent's Infonnation: Decedent research is when PHI is collected from deceased
(prior to the study) patients/subject's records.

Provide a description of the Protected Health Information (pHI) to be used or disclosed foi.' vour
research:
'age, gender, onset of diagnosis, number of pregnancies (full tenn, miscarriage, and abortion), number of
vaginal deliveries, height, weight pre-treatment, weight post-treatment, Body Mass Index pre-treatment,
Body Mass Index post-treatment, bladder irritants, prior exercise/activity level, CUlTent exercise/activity level,
obstacles to exercising, non-caffeinated fluid intake, primary complaint, secondiuy complaint, sacroiliac or
low back pain issues, abuse history, psych/social/sexual history, exercise/walking log (I-I.ome Exercise
Program), patient satisfaction survey responses, Sandvik Incontinence Severity Index Scores (lSI), Urogenital
Distress Inventory Scores (UDI-G), Incontinence Impact Questionnaire Scores (I1Q), electrode placement
(internal vs. external), biofeedback scores, Urine Stream Interruption ;fest Scores, general medical history,
brief obstehical/uro~,')'Ilecologic history, brief surgical history, and medications/supplements.

C. Source and Data Collection
1. Indicate your sources of health information:

o

Data containing no health information *

[gI Hospital/medical records (in and out patient)
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Physician/clinic records

0
0
0

Lab, pathology and/orradi610gy results
Biologicnl saml'les

.[gJ

Interviews/Questionnaires

0
0
0
0

·Psychotherapy Notes
Data previously collected for research purposes
Billing records
Other (describe bclow)

*Ifthe research does 110t include PHI. the HIPAA PrivCle-y Rule regulations do 110t apply to this research
study and you do not need to finish this J017n. Please be sure lO note 011 your initial review protocol
application that the research does not include PHI.
2. Indicate how the research team will access and/or receive hea:Ith information:

o With limit!Xi identifiers: ZIP codes, geocodes, dates of birth, or other dates only.
The study qualifies as a Limited Data Set andrequires a Data Use Agreement

[gJ With a code that can be liriked .t o the identity of the subject. '"
The research includes PHI because the I'esearch team will/iave health inJormation with identifiers.

o With unrestricted identifiers. *

*Requires Consent and Authorization Jrom the subject or a Waiver oJ Consent and WaiveI' oj Authorization
Jrom the IRE.
3. Indicate how the research team will record health information:

o Without any direct or indirect identifiers - as a de-identified data set
o With limited identifiers: ZIP codes, geocodes, dates of birth, or other dates only.
[gJ With code that c!m be linked to the identity of the subject.
o With unrestricted identifiers
n

D. Suniinal'v: Briefly summarize the coltection. use alld sharing oj PHIJar this research study.
All PHI in this study will collected through private chart reviews and recorded on a data sheet kept at the
University of North Dakota Physical Therapy Department. It will be reviewed and recorded by Cindy FlomMeland, and Brittany Carter, Ashley Waller, Rachel Hanson, and Kayla Bucher- students of physical ·therapy
at UND. The infonnation collected and the individual results will: only be shared between the researchers and
Lisa Martin MPT who will be the physical therapist providing the interventions.
E. Recl'Ilitmcnt: Please mark all that apply:

[gJ

I . PI/collaborators will recruit his/hcr/theirown patients.

02. PI will seud an IRB approved letter to colleagues asking for referrals of eligible patients.

The treating
physician will make initial patient contact. If the patient is interested, the patient will contact the PI.

o 3. PI will send an lllli approved lettcr to colleagues asking the physician to send oui IRE approved
general "Dear Patient" letters describing the research study. The PI may droft the letter with the
treating physicians ' signatllre. but may no/ have access to the patient names or addresses Jor mailing.
If the PI wants the lettel's to be personalized (Deal' A,fr. Doe), the personal inJormation would have {o
be entered by {he treatillg physician.

o 4. Advertisements/media. All recnti{me1!ll1laterials mllst have IRE approval.
D

5. The PI requests an initial Waiver of Authorization for the purpose of identi fying subjects for
recruitment purposes including (with pennission of the patient) the treating physician w.ill invite the
PI/research team to talk with the paticnt ahout enrollment. Be sure and complete section H.
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o 6. Other, please specify:
F. PHI Sharin~:
. t le course 0 f. the research stU:1y.
.d
I. Indicate who may J'eceive PHI dunng

[gJ StatistiCian
~ Colleagues (s) / Collaborators

o Other Research Laboratory (s)
o Study Data Coordinating Center
o Other. please specify:

o Consultants
o Data, Tissue, Specimen Registry(s)
o Sponsor! Funding Agency
~ Publication (s)

2. Indicate how the data will be shared or disclosed.
~ Without any identifiers.

0
.0

o With identifiers*.

With a linked code*.
As a Limited DataSet*.

* III this format. AlItl!orization must specifically note who data will be shared or disclosed to.
G. Data Security: Describe how the data will be secured. Please mark all that apply.
1. Electronic data:
secure network 0 password access
~ coded,with a master list secured and kept separately
other (specify):
2. Hardcopy dilt:l:

o

o

o locked suite [8J locked office
~ locked file cabinet
~ data coded by PI or research team with a master list secured and kept separately.
o data de-ideniified by PI" or·research team
o other: (specifY)

II. W!liYcr/Altcration of Authoriz!ltioll [Complete this section ·to rcquest a waiver of autho.riz!ltion for the
enti"re research protocol, for re.c ruitmcnt purposes, or to request an alteration of ·authorization
proccss such as no signed documentationj.
I. Describe the protected health infonnation (PHI) for which use, access, or disclosure is necessary. Include a
detailed list of thc PHI and also a list of the sources.

2. Criteria for Waiver/Alteration of Authorization:
A. Explain how the use and disclosure of ihe information presents no more than minimal risk to the
privacy of the individual.

B. Describe the plan to protect the identifiers from improper lise and disclosure (i.e., where will the
identifiers will be stored and who will have access).
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C. Describe the plan to destroy the identifiers at the earliest opportunity consistent with the cohduct of
the research. If there is a health or research justification for retaining identifiers or if such retention
is required by law, please provide this infOlmation as well.

O. Explain why the research could not be practicably conducted without the alteration or waiver.

E. Explain why the research could not be conducted without access to and use of the PHI.

F. The Privacy Rule rcqllires th1it when a waiver is granted that ohly the minimum necessary health
infomlation be used/disclosed. Therefore, provide justification: that the PHI being requested is the
minimum necessUlY infonnation reasonably necessary to accomplish objectives of the proposed
research.

STOP Continue to Section I
The University of North Dakota IRE determined thut this waiver requesJ satisfies all of the
requirements of the HIPAA Privacy Rule in 45 CFR 164.512(i)(2)).
[ ] 111e.proposed research activity will present no more than minimal risk to thepdvacy of the human subjects.
[ ] There is an adequate plan to protect the patient identifiers from iinproper use and disclosure.
[ ] There is an adequate plan to destroy the patient identifiers at the earliest opportuhityandior by the end of the
research study, or there is a health, research or legal justification for retaining th~ patient identifiers.
[ ] There are adequate assurances that the requested infonnation will not be rceused or disclosed to any other
person or entity, except as required by law, for authorized oversight of this research study, or for other
research for which the use or disclosure of the requested information would be permitted by the Privacy
Rule.
[ ] The research could not be practicably conducted without the Waiver for Patient AuthOlization to access and
lise the requested PHI.
[ ] The approval process was conducted by nOlmal review procedures.

Signature of IRB Chair or Member

1.

Date

HIP AA Pi'ivacy Rule Assurance
The information listed in the application is accurate and all research staff (investigators, key research
personnel) that are involved in the research will comply with the HIP AA reglliations. Further, I assure that
all research staff \-vill have completed the UND fRB research training requirement prior to research
participation.
5
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I assure that the information obtained as part of this research (including protected health illfOlmation) will
not be reused or discfosed to any other person or entity other than those identified on this form, except as
required by law. If at any time I want to reuse . this information for other purposes or disclose the
infonnation to other individuals or entities I will seek approval by the UND IRE.
4.~~-C.1

Date

Principal Inves gator SIgnature

6
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April 26, 2007
Dear

·IRB,

We, at
Physical Therapy, will be workulg with the Depa:ltment of Physical
TherapyaJ the University ofNOlth Dakota ina women's health study. We will be
collecting outcome data for our present urinary continence program, which provides us
with valuable information. We will continue to provide the best possible care for our
patients to reach the hjghest leveloffunctional outcomes, which ultimately affect quality
of life.
We look forward to working with Cindy Flom-Meland PT,PhD, NCS and studelits, at the
Department of Physical Therapy at the University of North Dakota.

Sincerely,

~1(fJt~rl
"-/ ~Lfs; Ma~il, MPT (

~~~~

Don Martin, PT
PI Coordinator

/.
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IUPAA i AUTH'ORIZATION TO USE AND DISCLOSE
INDIVIDUAL HEALTH INFORMATION FOR RESEARCH PURPOSES

1. Purpose. As a research participant, I authorize Cindy Flom-Meland, PT, PhD,NCS and the
researcher'S staffto use and disclose my individual health info11nation for the purpose of
conducting the research project entitled Effectiveness of Pelvic Floor Exercises in Women with
Urinary Incontinence.
2. Individual Health Information to be Used or Disclosed. My individual health information
that may be used or disclosed to .conduct this research includes: age, gender, onset of diagnosis,
immber of pregnancies (fuJI tern1,miscarrlage, and abortion), number of vaginal deliveIies, height,
weight pre-treatment, weight post-treatment, Body Mass Index pre-treatment, Body Mass Index
post-treatment, bladder irritants, prior exerQise/activity level, CUlTent exercise/activity level,
obstacles to exercising, non-caffeinated fluid intake, primary complaint, secondary complaint,
sacroiliac or low back pain issues, abuse history, psych/social/sexual history, exercise/walking log
(Home Exercise Program), patient satisfaction survey responses, Sandvik Incontinence Severity
Index Scores (lsi), Urogenital Distress Inventory Scores (UDI-6), Incontinence Impact
Questionnaire Sc:ores (IIQ), electrode placement (internal vs. external), biofeedback scores, Utine
Stream Interruption Test Scores, general medical history, brief obstel1icalJurogynecologic history,
briefsurgical history, and medications/supplements.

3. Parties Who May Disclose My Individual Health Information. The researcher and the
researcher's staff may obtain my individual health information from
MN.

4. Parties Who May Receive or Usc My IndividualHeaIth Information. The individual health
infqrmation disclosed by parties listed in item 3 and infonnation disClosed by me duting the course
of the research may be received and used by Cindy Flom-Meland, PT, PhD, NCS, the researcher's
staff, the lIND Research Development and Compliance office, and the UND Institutional Review
Board.

5. Right to Refuse to Sign this Authorization. I do not have to sign this Authorization. IfI
decide not to sign the Authorization, I may not be allowed to participate in this study or receive any
research related treatment that is provided tlU'ough the study. However, my decision not to sign this
authorization will not affect any other treatment, payment, or enrollment in health plans or
eligibility for benefi ts.
6. Right to Revoke. I can change my mind and withdraw this authorization at any time by sending
a written notice to Cindy Flom-~leland, Physical Therapy Department Room 1510, University of
North Dakota School of Medicine and Health Sciences, 501 N. Columbia Road Stop 9037, Grand
Forks, ND 58202-9037 to inform the researcher ormy decision. IfI withdraw this authorization,
the researcher may only use and disclose the protected ·health infornlation already collected for this
research stl1dy. No further health information about me will be collected by or disclosed to the
researcher for this study.

i

HIrAi\. is rhe Hcalih Insur.tnce Portability and Accountability Act of 1996. " federal law relnted to privacy ofhealih information.

HIPAA authori1..i!tion
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7. Potential for Re-disclosure. My individual health infonnation disclosed under this
authorization may be subject to re-disclos~lre outside the research study and no longer protected.
For example, researchers in other studies could use my individual health irifonnation collected.for
this study without contacting me if they get approval from an Institutional Review Board (IRB) and
agree to keep my infonnation confidential.
7A. Also, there are other laws that may require.my individuai health infonnation to be disclosed
for public purposes. Examples include potential disclosures if required for mandated reporting
of abuse or neglect, judicial proceedings, health oversight activities and public health measures.

I am the research participant or personal representative authorized to act on behalf of the
participant.
.
I have read this infoID1atioll, and I will receive a copy of this authorization form after it is signed.

Signature of r~e.1rcJl participan1 or research participant's

dale

Personal repre,scntative

PJin ~ ed name of research pal1icipanl or I'e:iea~h p:u'ticipant's
Pc:rson31 repti:s.:ntative

descliption qfpersonal representative's authority to act on behalf
(lfthe rt!Search·participnnt

HlPAA authorization

2
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Appendix B

INFORMATION AND CONSENT FORM
Effectiveness of Pelvic Floor Exercises in Women with Urinary Incontinence
You are asked to participate in a research study conducted by Lisa Martin MPT, Physical
MN, Cindy Flom-Meland PT, PhD, NSC,Assistant Professor
Th(:rapist at
of Physical Therapy at the UniverSity of North Dakota, and Kayla Bucher; Brittany Carter,
Rachel Hanson, and Ashley Waller, students of Physical Therapy at the University of North
Dakota (UND). This stuq.y is being conducted as a graduate school scholarly project. Please read
the information below and ask questions about anything you do not understand, before deciding
whether or not to participate.
The purpose of oill study is to measure the effectiveness of pelvic floor exercises On women with
urinary incontinence. Your participation in this study is entirely voluntary.
In order to participate in thjs stuq.y y01,1 must h,we cliagnosed pelVic floor weakness, stress
urinary incontinence; mixed (stress and urge) urinary incontinence, or uterine prolapse. You will
be exCluded from this study if you are male, have had surgical correction for UI, history of pelvic
cancer, severe endometriosis, or use of an intrauterine device. This Study does 'not experiment
wIth new exerci$es. You v411 be experiencing the same ,standard care that Meritcareprovides all
its patients with U1inary inc;ontinence. Yon wj.ll be asked to fiil outa survey, an initial
measurementofmus.cle activity wili be taken, and a home exercise program will be provided.
You will be se.en. for follow-up appointments as instructed by your physical therapist; Lisa
Martin, MPT.
Based on experience with pelvic floor exerc;i~es in patients w~th pelvic ~oor weakness,
researchers believe it may be of benefit to subjects with this condition. Of course, because
individuals respond differently to therapy, no ohe can know in.advance ifit will be helpful in
your particular case. However, the infonnationthis study obtains will help reinforce the
effectiveness of conservative treatment for patients in the future.
This type of exercise is considered low-risk; however, with any form of exercise; there can be
some risk for injury. If injury should occur, you and your third party payer will beTesponsible
for all charges .
Any information that is obtained in cOl1l1ection with this study and that can be ·identified with you
wiil remain confidential aild will.be disclosed only with your permission or as required by law.
YoU): record may beTeviewed by GQvemment azencies, the UND Research Development and
Compliance office, and the UND Institutional Review Board. Your name will not be associated
with any results of this study. There will be no audio/visual recordings ofparticipants. All data
will be destroyed three years after conclusion of the study. There will be no financial
compensation to either you or the researchers associated with this study.
You can choose whether or not to be in tillS study. If you volunteer to be in this study, youmay
withdraw at any time without COllsequences of arlY kind. You may also refuse to answer any
questions you do not 'want to answer.
Initials ofParticipmrt: _ _ _ __
IRE Number:
Dule of IRB Approval:
Projeci Expiralioll Dale:

Page I of2
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If you have any questions or concerns about this research, please contact Cindy Flom-Meland at
the University of North Dakota at
or Lisa Martin at
. You can
also reach any of the student researchers through the Department of Physical Therapy at the
University of North Dakota at .
between the hours of 8:00AM and 4:00PM.

If you have any questions about your rights as a research subject, you may contact the University
of NOlth Dakota Institutional Review Board (IRB) by telephone at
. You will be
giv~n the opportunity to discuss any questions about your rights as a research subject with a
member of the lRB. The lRB is an independent committee composed of members of the
University community, as well as lay members of the community not connected with UND. The
lRB has reviewed and approved this study.

.I UNDERSTAND THE PROCEDURES DESCRIBED ABOVE. MY QUESTIONS HAVE
BEEN ANSWERED TO MY SATISFACTION, AND I AGREE TO PARTICIPATE IN THIS
STUDY. 1 HAVE BEEN GIVEN A COPY OF THIS FORM.

Printed Name of Subject

Signature of Subject

Date

Data of lRB Approval:
IBlJ Number:

Page 2 of2

p,.oject Expiratioll Date:
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PARTICIPANT INFORMATION AND CONSENT FORM
TITLE: Effectiveness of Pelvic Floor Exercises in Women with Urinary Incontinence
STUDY DOCTOR(S): Lisa Martin MPT, Physical Therapist at.
., Cindy
Flom-Meland PT; PhD, NSC, Assistant Professor oEPhysical Therapy at llie University of North
Dakota, and Kayla Bucher, Brittany Carter, Rachel Hanson, and Ashley Waller, students of
Physical Therapy at the University of North Dakota

PURPOSE OF THE STUDY: The purpose of this study is to measure the effectiveness of
pelvic flbor exercises in worrien with urinary incontinence.

DESCRIp:rlON OF PROCEDURES: rfyou agree topruiicipate in lliis study, you will be
experiencing the.same standard care that
provides aU its patients with urinary
incontinence. Tllis research study does not experiment with new exercises. You will be asked to
fill out two surveys, an initial measurement.ofmuscle activity will be taken; and a home exercise
program will be.provided. You will need to be seen again in the clinic at 2 weeks, 4 weeks, and 3
months thereafter. Final muscle activity testing will be recorded at the 3 months visit. The
survey is expected to take 110 longer than 20 minutes to complete. The only research procedUre
is the completion of the surveys. Approximately 200 subjects will be recruited for the study.

RISKS AND .D ISCOMFORTS: Participation in this study should cause you to experience little
or ·no discomfort. This type of exercise is considered low-risk, however, with any form of
exercise; there can be some risk for injury. There might also be some mild discomfort regarding
placement oEiliternal muscle activity equipment if you choose to do so. This discomfort should
be minimized with use of visual aides and education of procedure. You will be asked for
personal inforination to be included in the records for this research study. This information will
be kept confidential, and you may refuse to answer any question that you do not wish to answer.
There is 110 medical risk.

ALTERNATIVE: You understand that your participation in this study is completely voluntary.
You may choose not to participate. Choosing not to participate will have no effect on your
current or future me.dical care or any other benefits you are already eligible to receive. If you
volunteer to be in this study, you may withdraw at any time without consequences of any kind.

Version Date: 22 May, 2007

Participant Initials: _ __
Date: _ _ _ _ _--,_
Page 100
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COMPENSATION: You Uliderstand that there will beno compensa~ion paid to you for your
participation in .this research study. If you believe that you have sustained an injury as a result of
your participation in this research study, you und~rstand that medical care will be available to
you; however, you, or your health plan, will be responsible to pay for the medical services you
receive.

BENEFITS: Based on experience with pelvic floor exercises in patients with pelvic floor
weakness, researchers believe it may be of benefit to subjects with this condition. Of course,
because individuals respond differently to therapy, no one can know in advance ifit will be
helpful in your particular case; Thc research may not benefit you personally. However, the
infOimation tIus study obtains wiII help reinforce the effectiveness of conservative treatment for
patients in the future.
CONFIDENTIALITY:
Any infonnationthat is obtained in connection with this study and that can be identified with you
will remain confidential and will be disclosed only with your permission or as required by law.
You will be assigned a code number that will go on the consent fonn, physical therapy intake
form, and surveys. This code will remain constant throughout the study and will beheld
confidential on paper; only the principal investigators will have access to the master list.

CONTACT PERSON: For mote infornlation concerning this research study and researchrelated risks and..iiljuries, you can contact Cindy Flom-Meland atthe University of North Dakota
at
or Lisa Martin at
. You can also reach any of the student
researchers through the Department ofPhysical Therapy at the University of NorthDakota at
hen",een the hours of8:00AM and 4:00PM.

If you want to ask questions about what it means to bein a research study or about your,rights as
a research participant, you can contact:

An institutional review board (IRB) is a group of people who review rescarch studies to protect
participants.

CONFIDENTIALITY: You lUlderstand that any information obtained about you, as a result of
your participation in this research study will be handled in a confidcntial manner. You
understand also that your research records, just like hospital records, may be subpoenaed by
court order or may be inspected by state or federal regulatory authorities. Also, you understand
Version Date: 22 May, 2007

Participant Initials: _ __
Date: _ _ _ _ _ __
Page 211f3
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your confidentirilrecords \vill be available to the others identified above as involved in this study
and their research staff (i.e; the University of North Dakota associates involved in this research
study and
associates involved in this research study). In any
publications that result from this research, neither your name nor any infomlatioll from which
you mi~ht be identified will be published without your authorization.

PARTICIPANT'S STATEMENT OF CONSENT AND AUTHORIZATION
You should not sign this Consent unless all oCtile following statements areirue:
I have read this form,and I have been able to ask questions about this study. The study doctor
a1id study staff has talked to me about this study. They haveansweted all of my questions. I
voluntarily agree to be in this study. I authorize the use and release 'o f my medical recor\is and
health information related to this study as described above.
By signing this fOrin I have not given up any of my legal rights as a.research participant.
understand that I will re!;eive a signeci.copy of this consent and authorization form for my
records.
Printed Name ofParticipant
Signature of Participant

Date

CONSENT STATEMENT
I attest that I or my representative discussed this study with the above-named participant. This
participant had enough time to consider this information, had an opportunity to ask questions,
and voluntarily agreed to participate in this study.
Printed Name of Person Explaining Consent
. Date

Signature ofPerson Explaining Consent

Signature of Study Doctor

Date

Version Date: 22 May, 2007

Participant Initials: _ _
Date: _ _ _ _ _ __
Page 3 oD
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HEALTH SYSTEM

AUTHORIZATION FOR USE AND DISCLOSURE OF INFORMATION
FOR RESEARCH PURPOSES

PATIENT NAME:
DOB.:
I authorize the us~~d disclosure of my individually identifiable health infonnation as
.described below. I understand that this authorization is voluntary. I understand that if
thepersoll or organization I authorize to receive the infonnation is not a health plan
or health care provider, the released infonnation may no longer be protected by
federal privacy regulations and could be re-disclosed.
Persons or organizations authorized to provide the infonnation:
All

entities

Persons or organizations authorized to receive the information:
"Any
entity or associate involved in this particular researchst)1dy.
"
Any University of North Dakota Medical School entity or associated involved in
this particular research study.
.,j
Govemment agencies that oversee clinical research testing (NIH, NCI, DIU-IS)
Specific description ofinfonnation to be used and disclosed, including dates:
Oral and written communication of and about:
All of my care and treatment at MeritCare
o My
care and treatment from
[date] to _ _ [date]
"
Other (specify): Any care or treatment involving physical therapy treatment for
urinary incontiilence.

o
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Purposes of the use and disclosure:
"

Research (specify study): Effectiveness of Pelvic Floor Exercises for Urinary
Incontinence

I ,urtderstand that my'health care and the payment for my health care ~rill notbe affected if
I do not sign this form,. except that research-related treatment may not be provided if I do
not sign this fOffil.
I understand that this authorizatipn will not expire, but will continue indefinitely, urtless I
specify another date or event for expiration.
(Specify date Q1"event) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
I understand that I may revoke this authorization at any time by notifYing
's
Privacy Officer in writing. I understand that in revoke this authorization, my revocation
will not have arty effect on actions
took before it received my Tevocation, and
that
may conti.nue to use, for research purposes, the information it obtained
before my revocation.

Signature of Patient or Patient's Representative

DatelTime

If signed by patient'srepresentalive, piease state authority of representative to act for
patient:
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1. Human Subjects: Characteristics
Institutionalization
Group
Ages*
Type of
Institution
(tir«le
one)
Control
Inpatient
Group
Outpatient
Experimental
Inpatient
OutQatient
Other Group
(specify)

Special
Group (if
yes,
e~plainl

State of Health
Physical Health
Mental Health
Relevant to
Relevant to
Research (if
Rese.a rch (if yes,
Explain)
Yes, eXj!Jain)

Assessing
outc.omes of UI PT
intervention

Inpatient
Outpatient

*If study group includes minors (ages 17 and under), please attach the primary
investigator's assessment on the issue of whether minor assent is appropriate and for
which age category of minors that may be involved in the study. The IRS will c:\etermine
if minor assent is appropriate. If the IRS determines that assent is appropriate for some
or all of the minors involved in the study, verbal. assent is sUfficient. Generally, minor
assent is not required in the following circumstances:
1. If the capability of some or all of the minors involved in 'the study is so limited that
they cannot reasonably be consulted;
2. If the intervention or procedure involved in the research holds out the prospect of
. direct benefit to the health or w~lI-being of the children .and is available only in
the context of the research; and,
3. If the research meets the same conditions as those for waiver of alteration of
informed consent in research involving adults as speCified in the IRS manual,
pages 30-3 t.
The primary inve'stigator's Elssessment of the minor assent issue should address the
above factors, if rel¢vant to the stljdy or for any particular age group of minors involved
in the study. See IRS Manual, page 36 for more information on minor assent.

2. Possible Risks Involved (When high or medium risks are present), please
explain.
Risks

Physicid

High
Risk
a. Loss of like, organs,
tissue
b. Impairment due to use of
drugs or to surgical
procedures, or due to
withholding of drugs or
surgical procedures.
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Medium
Risk

Some
Risk

No Risk or
not
Relevant

c. Injury due to exposure to
infections or parasitic
organisms, to radiation,
immunologic sensitization,
nutritional imbalance or
mutagenic agents.
d. Other (specify)

Psychological

a. Loss of or threat to selfesteem.
b. Development or
exacerbation of anxiety or
guilt feelings.
c. Breakdown of or
initiation of doubts
regarding values of
significance to the society
or to the indiVidual.
d. Generation of .c onflict in
or threat to interpersonal
adjustment.
e. Other (Specify)

Social and
Ecc>nomic

a; Public humiliation and/or
economic loss resulting ·
from release of information
in which a subject can be
identified(sllecified).
Legal sanctions from
maintenance of files in
which subject can be
identified and which might
expose him to legal or other
action.
Other (e.g., family and
marital, specify)

x-

*
See
beloW

Estimated duration of study:
The student researchers will be involved for up to 6 months. The two physical
therapists (Lisa Martin and Cindy Flom~Meland) plan to continue the research for 2
years.
Additional Comments:
*with any form of exercise there can be some risk of injury; there may also be some mild
discomfort regarding placement of internal muscle activity equipment.

Signature of Principal Investigator

Date
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Appendix C

UDI-6
Directions:
The following symptoms have been described by women who experience accidental
urine loss and/or prolapsed. Please indicate which symptoms you are now experiencing,
and how bothersome they are for you. Be sure to answer all items.

*** Please circle your response ***
Urogenital Distress Inventory-Short Form UD1-6

Do you experience, and if so, how much are you bothered by:
1. Frequent urination?
Not -at all

Slightly

Moderately

Greatly

2. Urine leakage related to the feeling of urgency?
Not at all

Slightly

Moderately

Greatly

3. Urine leakage related to physical activity, coughing, or sneezing?
Not at all

Slightly

Moderately

Greatly

Moderately

Greatly

Moderately

Greatly

4. Small amounts of urine leakage (drops)?
Not at all

Slightly

5. Difficulty emptying your bladder?

Not at all

Slightly

6. Pain or discomfort in the lower abdominal or genital area?
Not at all

Slightly

Moderately
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Greatly

IIQ-7
Directions:
Some women find that accidental urine loss and/or prolapsed may affect their abilities,
relationships, and feelings. The questions below refer to areas in your life which may
have been influenced or changed by your problem. For each question, check the response
that best describes how much of your activities, relationships, and feelings are being
affected by urine leakage and/or prolapse.

*** Please circle your response ***
Incontinence Impact Questionnaire- Short form IIQ-7
Has urine leakage and/or prolapsed affected your:

1. Ability to do household chores (cooking, housecleaning, laundry)?
Not at all

Slightly

Moderately

Greatly

2. Physical reaction such as walking, swimming, or other exercise?
Not at all

Slightly

Moderately

Greatly

· 3. Entertainment activities (movies, concerts, etc)?
Not at all

Slightly

Moderately

Greatly

4. Ability to travel by car or bus more than 30 minutes from home?
Not at all

Slightly

Moderately

Greatly

5. Participation in social activities outside your home?
Not at all

Slightly

Moderately

Greatly

6. Emotional health (nervousness, depression, etc)?
Not at all

Slightly

Moderately

Greatly

Slightly

Moderately

Greatly

7. Feeling frustrated?
Not at all
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Sandvik Severity Index
The severity index, developed by Sandvik et aI, is an easy and reliable way to assess the
severity of the incontinence problem (Sandvik et aI., 1993; Hanley, Capewell, & Hagen,
2001).
How often do you experience urine leakage?
0= never
1 = less than once a month
2 = one or several times a month
3 = one or several times a week
4 = every day and/or night
How much urine do you lose each time?
1 = drops or little
2 = more
The severity is described by the total score, which is the score for the first question
multiplied by the score for the second question
o= no incontinence
1-2 = slight
3-4 = moderate
6-8 = severe incontinence
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Appendix D

Symphysis
Pubis

Urethral
Opening

Pubococcygeus

lliococcygeus

Endopelvic Musculature
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PELVIC FLOOR EXERCISE PROGRAM

How to perform: The muscles you want to strengthen are the muscles that stop the flow of urine.
Avoid holding your breath, and relax other Illuscles.
1. Short contractions: "Flicks"
Hold ___ seconds, relax___ seconds
Begin with
reps/time
Goal: ,repeat ___ times! day

Decide on a specific time of day in \vhich you will perform these" or an activity that is done daily
such that performing these becomes habit.
2. Endurance contractions: "elevators"
Hoid .___ seconds, relax_ _seconds'
repeat
reps/time
Goal: _ _sec hold
Exercise position
Faucet Test:
Monitor your progress lxIwk"by attempting to:stop the flow of your urine. If your pelvicHoor
muscles .a re strong you should be able to 'perform this \vith ease.
Suggestions:
• Eat a high fiber diet to avoid constipation and pressure on the bladder
• Get good water intake daily
• Avoid caffeine and nicotine
• Continue to consume min. 8 glasses of water! day
Success of this proeram depends on your complia:nce with the exercises!
If questions, please call
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Nrune________________________________~____~Date__________________

o

D
D

D

Caffeine Eliminated

cups/day

Non Caffeinated Fluid/Day - 6~8 glass('!s
Purposeless Activity/Day - 20 minutes/day
Physiological Quieting
Audiotape 20 minutes/day
Hourly diaphragmatic breathingthand warming

Fab1.ilous Font Exercises

D

HOME PROGRAM

BEYOND KEGELS SELF CARE ·-

Minutes

1. Relaxed Awareness of the Pelvic Muscles
Focus on your breathing.
Release head to toes into the support
Focus on pelvic muscles.
Liftup/tighten gentlYithen release 3-4 times.

D

2A: Assisted Pdvic Muscle Tightening - Addu:ctors
Roll your knees iIi. on Soft ball
as you lift up anci in With pelvic muscles.
Hold for 10 counts, release for 10 counts.

D

2~. Assisted Pelvic Muscle Tightening -Obturators.
Roll your legs out against elastic band,
as you lift up a,nd in with pelvic muscles.
Hold for 10 counts,release for 10 counts.

D

3. Quick Contractions of the Pelvic Muscles

1JJII[
I . .

Lift pelvic muscles up and in quickly and release quickly. .
"
Maximum
Think uti'ghten, reIease, tighten, release.
contraction
Repeat 6-10 times at the beginning and end of
each session. .
.
Resting
.

D

4. Standing Plie

lovol

.

Stand witll feet pointing outward hip width apart.
Bend knees as you exhale, tightening pelvic muscles.
Then slowly straighten knees as you inhale. Relax.
Bend knees to a count of 5, straighten to a count of 5.
Release/relax the pelvic muscles to a count of 5.
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lighten

I

. R ·I

I I 1°1"'\ I I I

Personal Exercise Program

Q

Phya:ioTool. Ltd

Diaphragmatic Breathing.
Lie on back with knees bent and both hands on the upper part of stomach.
Breathe in slowly through the nose and breathe out slowly through the
mouth.
During breathing in the hands on the stomach rise and when breathing out
the hands go down .

........,--=-,.- - - - Built on Tools® RG
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Bridge

Bridging -lifting the hips "unloads" the pelvic floor.
Tighten pelvic floor muscles with" Belly to spine".
Hold

sec. Relax

_.__ Reps. _ _ Sets
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sec.

Bridg~withT·

....

.

-

,.... ,

."::'."

.... ",

balld

':

'

"

.--'

. .. .::

.

.... .:::.: ." ....

':.'"

Tighten the pelvic floor muscles with" Belly to' spine". Then with thet- band tied
above the knees pull band apart as you maintain the bridge and "Kegel" contraction.
Hold

sec. Relax

sec.

Repeat _ _ Reps. _ _ sets
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Bridge OverBall

• ••••

•

v

Tighten pelvic floor. "Beily to spine" as you lift up iritoa bridge position.
Hold

sec. Rela x

sec.

Repeat ___ reps. _ _ sets
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Sitting on Ball Exercise

Tighten pelvic fioor as you press arms ' .' . . .
wa'ii. Per your
physical therapist, you m~yatiempt to tighten the peivic floor as you roil the ball
forward/ backward; side to side; or in a diagonal direction.
Hold

sec. Relax

sec.

Repeat __ . reps . ___ _ sets
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T-bandandBall Exercise
...... ' ., ;!

Sitting on a ball, pull legs apart and roll outward against thel-band as you
tighten the pelvic floor, Pull your shoulder blades downward and back,
Hold
Repeat _

sec , Relax

sec,

reps , _ _ sets
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Ball in Diagonal Direction Exercise

o

.-.

..

..... . .

Diagonal muscle fibers 6f the pelvicfl60r can be contracted
bali is pulled from the right sitting bone towards the left knee, vice versa .
Tighten pelvic floor muscles.
Hold

sec. Relax

sec.

Repeat _ ___ reps. ______ sets
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Gold Fish position
.I

In face down position over the ball, press legsl heels
together as you tighten pelvic floor muscles.

Hold _
Repeat _

sec. Relax -:--- sec.
reps. _
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sets

The pelvic floor is "unloaded" in a low puppy position.
Perform p~lvic floor tiahtening as' follows : .
Hold

sec. Relax

____ Reps.

sec.

_ _ minutes
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walldngExerciseProgi:'aiIi*
A. ) 'Under 30 Yeat"s of

A9: e :
WHk

Oi~61!a'

r_GoII

(mil4s)

(mmittfS)

Ft'f(i/WIc

PoinlflWk

2.0
Z.O
2.0

34:00
32:00
30£0
3&00
37:00
36,00

3
4
5
5
5

45,00

5

lZ.Z
18.0
25.0
31.8
33.2
34.6
40.0
41.3
4Z.9

2,5
2.5
Z.5

4

5
6
7
8

3.0
3.0
3.0

,9

3.b

10

~'

44,00
43,00
42:00

5
5

:is.4

,&i tI>o 10th, ~ an ~t. 1_1 ~! ~le ccndi,tic".. hu 'b Mn C"MChed .. can be
ioUnWiiodviCh A ,. X pjle ~I.: ochoduJ... 't\Il.a ltoYti Q! ,_eelM .q,w. :is ~c Poinb
pjle w..x, CoiIai.corit viCh the goQd e&t"90CY of _ i e 'UtnUa.

B. )

'rhitty to 49 Years of A9: e :

4

5
6

7
8
9
10

r;-GoI./

0ist61!a
(mil6sj

(min)

F~

PointSlWk '

2.0
'2.0
2;0
'Z.O
Z.5
'Z.5
Z.5

36:00
30\,00
32:00
30:00
39,00'
38:OC)
37:00

3
3

I,U ;
lZ.Z
18.0
20.0
24.5
31.8
33.2
38.7

WHo\'

3.0
3.0
l.ll

4
4
4

5
5
5
5

~'OO

45:00
44,00

~.O

:!J.l

4

By tho 10th _ . an odiquI.to' level ot· M<Obie, ccnditicnin<J hu been e ...ch«! .. can
r..intained vith " 4X Poe _k ect>.dul.. '!hb h\'el ot" eJiocciM «;UAla 33 .«robie
poinus pee _k, """"i3t«tlt. vith the 900d cat"90'Y of "«oie titnU..

be

c.)

Fifty Years of Age

&

Older:
,OIst6(1(#

WHk

,(m;,,)

1.0
1.5

20:00
30,00
4(}.00
38:00
36:00
34:00
4Z:OO
40:00
38:00
47,00
46:00
45:00

Z.O
4

5
6
7
B

9
10
II
lZ

r_ ,GoI/

(mil6s)

2.0
Z.O
2.1i
2.5
2.5
2.5
3.0
3.0
3.0

4.0

4
4

8.0
lZ.0
13.3
14.7
16.2
Zi.7
23.5
25.5
30.0
31.0

32.0

By ~e 12th wek, an ~t. leve;l of .ecobic conditioni.ng ha.s been eeachod , can
be ~iilt.ained with 4 eXGC'ciH perio::1.t each w.k.
'1'h.i.1 leval 01. uecciM equa.l.s 32
aet"obfc p'oin~ pot' \IHk, CO(W~'-t~t vi-th th.cr ~ cac.go·cy of .... robic fi~.

*The AeLObic Pt"ogram foe Total Well-Being, KennethH. Coopet" , MD, MPH, Bantam Books,
Tot"onto, 1982.
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URiNARY INCONTINENCE PROGRAM
BLADDER TRAINING

• Increase voiding interval
• No scheduled night void
.•

Ur~e sUppression
- stop andsh - relax and breath- distract your thoushts (puff and tuck) - tighten pelvic
flooras you exhale out of your.mouth

ayoid bladder irritants: caffeine, nIcotine, soda, alcohol
continue to increase voiding interval

NQRMAL BLADDER FUNCTION

Nm:mL

Number ofvoios per day'
Number of glasses of 8 oz. Fluid to drink/day
Voiding interval
Number ofvoidipg episodes at night (nocturia)
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7
6-8 (of which half of this should be water)

2-5 hours between trips to the bathroom
0-2 times

.... _._... __._-----_.

__ _-_._._._._----...

History/Diary

ConstipatiDn/Diarrheal
Fecal Soiling
Gllals
I: Improve functional strength of levator ani and
sphincter musculatUre.
2. Increase frequency of normal bowel movements.
3. Increase functional activities without fecal soiling.
4. Eliminate diarrhea. constipation. fetal soiling.
S. Decrease paradoxical puborectalis contrJctions.

< aae IiaYteI movement/day
fecal sbilalng at underWear
mediAti•• Drent;masllsed
far N'wi':1 mmiement

Plans
I. 6-8 glasses of fluid daily
2. Eliminate caffeine & alcohol
3. Cooked 0( raw fruit);/vegetables
• one at breakfast.
• two at lunch. tWo al dinner
• prunes and apricots are good
4. Bran.llndyogurt at hreakfast
• 1-2 teaspoons wheat bran/day
• 4-6 ()z yogurt
5. Magnesium 250-500 mg
Vitamin C 250-2000 mg (not recommended if renal
failure-or interstitial cystitis)
6. Fabulous Four Exercises
• 2-3 x/day for 5-1 minutes
• emphasize equal rest and Contract time
• emphasize obturator and a4ductor assist exercises
7. Nonpurposeful Moderate Aerobic Exercise
• tO-3~ min daily
• in a.m. if possible
8. Physiological Quieting
- 20 min . daily at bedtime
-hourly diaphr.agmatic breathing
9. Myofascial Release
• pelvic diaphragm release
• sacral mobility
• visceral motility
I D. Sel f massage
• clockwise circular massage from lower right :abdomen up. across and down lower left abdomen
• daily before arising
- follow with drinking 2 cups of warm water
II . After a bowel movement roll knees in & out 2-3x to
facilhate complete evacuation.
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stnlalnll to have bowel

milvemBnl

feeling ot
IncDmpleti: liowelmovement

Instructions:

Monday, Date
6-S .am

Continence Program
Weekly Bladder Record
Name: _________
Weekof:, _ _ _ _ _ __

Insert the following symbols
into the appropriate time
spaces . . .
T = toilet UrilUlry
F = Boz. fluid
B = bowel movement )(- = aiffeirmted
L =~;mallleak
P = Pnd
A = large leak

TuesdaYr.Date

Wednesday, Date

6-Sam
8-10
10-2

6-8 am
8-10
10-2
12-2 pm
2-4

12-2 pm
2-4

8-10 .
10-2
. 12-2 pm

2-4
4-6
6-8
8-10
10-12Overnight __________
. "Pads used ________
comments_ _ _ _~_ __

Thursday, Date
6-8 am
8-10
10-2
12-2 pm
2-4

4-6

4-6

4-6

6-8
8-10
10-l2

6-8

8-10
10-12

6-8
8-10
10-12

Overtright,._ _ _ _ _ _ __
*l'ads used _ _ _ _- - comments__________

Overnight _________
*Pads used ___________
conunents~
. _ _ _ _ _ ____

Overnight _____________
"Pads used --------comments_·_____~---__

friday, Date

Saturday, Date

Sunday, Date

.6-Sam
8-10
10-2
12-2 pm
2-4
4-6
6-8
8-10
10-12

6-Sam
8-10
10-2
12-2 pm
2-4
4-6
6-S
8-10
10-12

Overnight
""Pads used
cOJll:qlents

Overnight
"Pads used
comments
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6-Sam
8-10
10-2
12-2 pm
2-4
4-6
6-8
8-10
. 10-12

Overnight
*Padsused
comments

Appendix E

Data Collection
Age: _ _ _ _ __
ID#:- - - - - - - - Gender: Female
Diagnosis: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Onset~
. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Primary complaint _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Secondary complaint _________________________

General medical history: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Obstetricallurogynecologic history: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Surgical history: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Sacroiliac or low back pain issues: Yes
Abuse history:

Yes

No

No

Psych/social/sexual history: ______________________

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - .Medica
tions/Supplements: _____________________________
- - - - - - - - - - - - - - - - - - - - - - - - - - - -Bladder
Irritants:
---------------------------Number of pregnancies:_ _ _ _ _ _ _ _ _ _ __
mlscamage: _ _ _ __ abortion:- - - full term: - - - - - Number of vaginal deliveries:
----------Non-caffeinated fluid intake:
----------------------Height: _ _ _ _ _ _ _ __
Weight pre-treatment________
Weight post-treatment _ _ _ _ __
Body Mass Index pre-treatment _____ Body Mass Index post-treatment _ _ __
Prior Exercise/Activity level:- - - - - - - - - - - - - - - - - - - - - - Current Exercise/Activity level: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Obstacles to exercising: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Sandvik Incontinence Severity Index Score (lSI)
Initial:
Final:- - - - - - - Urogenital Distress Inventory Score (UD1-6) Initial: _______ Final: _ _ _ __
Incontinence Impact Questionnaire Score (IIQ) Initial:
Final: _ _ _ __
Final:- - - - - Urine Stream Interruption Test Score initial:
Electrode placement Internal
External
Biofeedback initial:
Biofeedback post _ _ _ _ _ _ _ __
Exercise/walking log (Home Exercise Program): _ _ _ _ _ _ _ _ _ _ _ _ _ __
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